Patent · US Active

Pharmaceutical composition containing crystalline macitentan

US9730932B2 · kind B2 · utility

0Cited by
1References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 17, 2014
Grant dateAug 15, 2017
Priority date—
Expiry dateApr 17, 2034

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB65D2565/388
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to an oral solid dosage form, in particular a tablet, comprising macitentan free base polymorphic form I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.